Pfizer on Tuesday officially submitted an application with the FDA for emergency use authorization of its COVID treatment pill, 10 million courses of which are to be purchased by the Biden administration, CNBC and The Washington Post report.
The White House is expected to announce the "multibillion-dollar investment" this week, which officials "hope will help change the trajectory of the pandemic by staving off many hospitalizations and deaths," says the Post. If authorized by the FDA, the Pfizer drug has the potential to "revolutionize the fight against COVID" by allowing high-risk individuals to treat themselves at home rather than in a hospital, writes CNBC. When taken alongside a common HIV drug and within three days of the onset of symptoms, the pill reduces hospitalization and death by 89 percent, Pfizer said.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
According to The New York Times, both the Pfizer and Merck treatments are meant for high-risk, unvaccinated individuals, and are "are geared toward older people or people who have obesity or medical conditions that put them at elevated risk" of severe COVID.
"We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients," said Pfizer CEO Albert Bourla on Tuesday, "and we look forward to working with the U.S. FDA on its review of our application, along with other regulatory agencies around the world."
-
‘Mental health care is health care’Instant Opinion Opinion, comment and editorials of the day
-
6 Broadway shows coming to a local theater near youThe Week Recommends Harry Potter makes an appearance. As do the wives of Henry VIII.
-
Judge rejects top state charges in Mangione caseSpeed Read If convicted, Mangione faces up to life in state prison
-
SpaceX breaks Starship losing streak in 10th testspeed read The Starship rocket's test flight was largely successful, deploying eight dummy satellites during its hour in space
-
Rabbits with 'horns' sighted across Coloradospeed read These creatures are infected with the 'mostly harmless' Shope papilloma virus
-
Lithium shows promise in Alzheimer's studySpeed Read Potential new treatments could use small amounts of the common metal
-
Scientists discover cause of massive sea star die-offSpeed Read A bacteria related to cholera has been found responsible for the deaths of more than 5 billion sea stars
-
'Thriving' ecosystem found 30,000 feet underseaSpeed Read Researchers discovered communities of creatures living in frigid, pitch-black waters under high pressure
-
New York plans first nuclear plant in 36 yearsSpeed Read The plant, to be constructed somewhere in upstate New York, will produce enough energy to power a million homes
-
Why Elon Musk's satellites are 'dropping like flies'Under The Radar Fierce solar activity destroying Starlink satellites
-
Dehorning rhinos sharply cuts poaching, study findsSpeed Read The painless procedure may be an effective way to reduce the widespread poaching of rhinoceroses
